Dr. Lilly Xu Named President of Shanghai ChemPartner

ChemPartner announced the appointment of Dr. Lilly Xu as President of Shanghai ChemPartner. Dr. Xu, who has a Ph.D. in molecular and cellular biology, joined ChemPartner in 2017 and has since led strategic drug discovery services as Senior Vice President and Head of DMPK and Exploratory Toxicology. Prior to joining ChemPartner, Dr. Xu held various management positions in US biotech and pharmaceutical companies such as Amgen and Sanofi US. At Sanofi US, she headed the Center for Predictive ADMET and holds a green belt in Lean 6 Sigma. During her time in academia, Dr. Xu pioneered the use of human and animal hepatocytes in drug metabolism and drug-drug interactions.

"We are confident that Dr. Xu can leverage her deep knowledge of drug discovery and her proven organizational leadership experience to accelerate the growth of Shanghai ChemPartner," said Xianwei Zeng, Board Chairman and CEO of ChemPartner.

ChemPartner is a leading global CRO and CDMO that provides integrated life science services for drug discovery and development. With expertise in discovery chemistry, biology, pharmacology, DMPK, exploratory toxicology, biologics discovery and development, and biologics manufacturing, ChemPartner is uniquely positioned to be a biopharmaceutical alliance partner. The company's mission is to provide high-quality R&D services while helping customers advance their projects in a timely and cost-effective manner.

"I am excited to take on this new leadership role at ChemPartner and work closely with our highly experienced executive team to achieve our company's vision and goals. My drug discovery and development operation experience combined with the team's expertise provides ChemPartner's global clients with the skills and proficiency they need," said Dr. Xu. "I am enthusiastic about the unique service offerings at ChemPartner as well as the potential for additional growth."

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!

Sign up now!

  • <<
  • >>

Join the Discussion